Gelatin
As of the edition of 20 October 2026, Gelatin is a drug: marketed, first approved in 1998 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1998
- Kind
- Unknown
- Brand name
- Plasmion
- First approved
- 4 June 1998 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Fresenius Kabi
- Registered trials
- 10, 1 stopped early
- Disease areas
- Heart and blood vessels; Infections; Cancer; Hormones; Inherited and neonatal; Lungs and airways
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 3 | 3 | 0 | 0 |
| Phase 1 | 3 | 3 | 0 | 0 |
| Phase 2 | 2 | 2 | 0 | 0 |
| Phase 4 | 2 | 0 | 1 | 1 |
| All trials | 10 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| GSK | Lead sponsor of trials | 2014 to now |
| B. Braun Melsungen | Lead sponsor of trials | 2015 to now |
| AstraZeneca | Lead sponsor of trials | 2021 to now |